rawfin.tv
Eton Pharmaceuticals CEO Sells $6.08 Million in Company Stock
MarketsstocksAI Generated

Eton Pharmaceuticals CEO Sells $6.08 Million in Company Stock

By rawfin.tv Markets Desk||1 min read|AI-assisted Β· Methodology

Sean Brynjelsen, CEO of Eton Pharmaceuticals, recently sold approximately $6.08 million worth of his company's stock. This significant insider transaction could signal a shift in executive confidence.

Eton PharmaceuticalsInsider SellingCEO TransactionsPharmaceuticalsExecutive Activity

Related Articles